Operating CF
$1.21B
Capex
−$126.63M
Free Cash Flow
$1.08B
FCF Margin
+89.5%
Cash flow waterfall for IDEXX Laboratories (IDXX) — TTM through Q1 2026
Free cash flow: $1.08B
Cash flow breakdown for IDEXX Laboratories (IDXX) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $1.21B | $1.21B |
| Capital Expenditure | −$126.63M | $1.08B |
| Free Cash Flow | $1.08B | $1.08B |
| Other Investing | −$13.54M | $1.07B |
| Share Buybacks | −$1.17B | −$100.93M |
| Net Debt Change | $32.12M | −$68.81M |
| Other Financing & FX | $105.37M | $36.56M |
| Net Cash Increase | $36.56M | $36.56M |
- Operating Cash Flow$1.21B
- Capital Expenditure−$126.63M
- Free Cash Flow$1.08B
- Other Investing−$13.54M
- Share Buybacks−$1.17B
- Net Debt Change$32.12M
- Other Financing & FX$105.37M
- Net Cash Increase$36.56M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement